During the past decade, Clinique Victor Hugo conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 14 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 10 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Victor Hugo" #1 sponsor was "The Lymphoma Academic Research Organisation" with 10 trials, followed by "Celgene" with 8 trials sponsored, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 8 trials sponsored, "Pfizer" with 6 trials sponsored and "UNICANCER" with 6 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Victor Hugo" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Celgene Corporation" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator and "Intergroupe Francophone du Myelome" with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Victor Hugo" are "Multiple Myeloma" (6 trials), "Breast Neoplasms" (5 trials), "Breast Cancer" (4 trials), "Pancreatic Cancer" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Clinique Victor Hugo" in a lesser frequency.

Most popular intervention types in "Clinique Victor Hugo" are "Drug" (76 trials), "Biological" (11 trials), "Other" (9 trials), "Radiation" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Rituximab" (7 trials), "Prednisone" (6 trials), "radiation therapy" (6 trials) and "Docetaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Victor Hugo" are 73 trials for "All" genders, 9 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Victor Hugo". undefined are not yet recruiting, 13 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Clinique Victor Hugo, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Victor Hugo, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Clinique Victor Hugo has several departments that took part in Clinical trials: "Centre de cancérologie Les Dentellières" - 12 trials, "Institut de Cancérologie Paris Nord" - 10 trials, "Clinique Cardiologique Aressy" - 2 trials, "GCS RISSA - Institut de cancérologie Paris Nord" - 2 trials, "Centre d'Oncologie et de Radiotherapie de Chaumont le Bois" - 2 trials